Diagnostic mtDNA analysis in body fluids other than blood Sarah Ball 1, George Gray 1, Ros Quinlivan 3, Paul Brown 4, Chris Hendriksz 2 Birmingham Children’s.

Slides:



Advertisements
Similar presentations
Polymorphism & Restriction Fragment Length Polymorphism (RFLP)
Advertisements

Medical Genetics 13 线粒体疾病 mitochondrial diseases.
Auditing antenatal diagnoses – what is good practice? Sarah Ball, Tim Hutchin, George Gray, Linda Jenkinson, Mary Anne Preece West Midlands Laboratory.
A mutation of the mitochondria Katarina Mendoza and Kaytee Smith Myoclonic Epilepsy with Ragged Red Fibers (MERRF)
CRITICAL APPRAISAL Bob Lightowlers Mitochondrial Research Group Institute of Neuroscience.
13.3- The Human Genome. What is a genome? Genome: the total number of genes in an individual. Human Genome- approx. 20,000 genes on the 46 human chromosomes.
DNA marker analysis Mrs. Stewart Medical Interventions Central Magnet School.
Chris Campbell West Midlands Regional Genetics laboratory
Prenatal diagnosis Dr Neda Bogari.
What is Genetic Testing? And what is its value? Sherri J. Bale, Ph.D., FACMG President and Clinical Director GeneDx.
Genetic Counseling & Genetic Testing Katelyn Meadows & Betty Hagerman.
Genetic Testing for Wilson Disease Melissa Dempsey, M.S., CGC The University of Chicago Genetic Services Laboratory July 17, 2010.
Biology Revision DNA PROFILING. VARIATIONS OF VNTR ALLELE LENGTHS IN 6 INDIVIDUALS.
Preventing HIV/AIDS There is no way to tell just by looking whether a person is infected with HIV. Because people are unaware that they are HIV-positive,
Y.Martinez.
In Vitro Fertilization and Preimplantation Genetic Diagnosis
Urinalysis.
Genetic counselling Mary Porteous
Affymetrix Resequencing Arrays Matthew Smith Trainee Presentation West Midlands Regional Genetics Laboratory.
Duchenne Muscular Dystrophy: The Diagnostic Process.
Laboratory Training for Field Epidemiologists Viral cultures Investigation strategies and methods May 2007.
Expanded PLA2G6 Copy Number Variant Analysis in Patients with Infantile Neuroaxonal Dystrophy (INAD) Danielle Crompton, P. K. Rehal, L. MacPherson, K.
MEDICAL LABORATORY TECHNOLOGY What will I do? Perform tests on human blood, tissue and fluid Be a part of the health care team Help the doctor diagnose.
Apparent homozygous deletion identified in Alström syndrome patient Elizabeth Perrott West Midlands Regional Genetics Laboratory.
A RAPID AND INNOVATIVE METHOD FOR THE IDENTIFICATION OF THE COMMONEST G6PD ITALIAN MUTATIONS A. Minucci, L. Gentile, S. Rocchetti, C. Zuppi, B. Giardina.
Visualizing DNA. What is it?  Gel electrophoresis is one of the techniques scientists use to look at the DNA they have.  This technique separates DNA.
Mitochondria 90% of ATP generated there 10 to 1000s per cell (highest in brain, skeletal muscle, heart, kidney, liver) About 50 known mutations of human.
Laboratory Careers Packet #4. Introduction Individuals working in this field have various tasks, duties, interests and abilities. Laboratory personnel.
9 th Medical Genetic Course Center for Biomedical Researh (CEBIOR), Diponegoro University, Semarang, Indonesia In collaboration with Radboud University.
Genetic Disorders Diseases. What is a Genetic Disorder or Disease? A genetic disorder is an abnormal condition that a person inherits through genes or.
Molecular Genetics in the Von Willebrand disease Ghasem Rastegarlari.
Avoiding Transmission of Genetic Disease Avoiding Transmission of Genetic Disease Professor Peter Braude Division of Women’s Health Kings College, London.
Biochemical markers for diagnosis of diseases and follow up Dr. Rana Hasanato Associate professor and consultant Head of clinical chemistry department.
Copyright © 2016 McGraw-Hill Education. All rights reserved. No reproduction or distribution without the prior written consent of McGraw-Hill Education.
What Do You Want To Know About Thalassaemia (Carrier)
4.3 Alterations In Chromosome Structure and Number
Human Genetic Disorders Notes. What causes genetic disorders? Mutations, or changes in a person’s DNA.
Crime Scene Investigator PCR Basics™
PCR Y.Martinez, LSHS, 2014 DIRECTIONS: COPY NOTES IN ORANGE.
Copyright © 2009 Pearson Education, Inc. PowerPoint ® Lecture Presentation for Concepts of Genetics Ninth Edition Klug, Cummings, Spencer, Palladino Chapter.
The Factor II (Prothrombin) G20210A Detection and Genotyping
KEARNS-SAYRE SYNDROME (KSS) By: Emily Tucker. When did Kearns-Sayre Come About?  Thomas P. Kearns and George Pomeroy Sayre (1958)  Clinical triad of.
Chapter 8 Additional DNA Markers: Amelogenin, Y-Chromosome STRs, mtDNA, SNPs, Alu Repeats ©2002 Academic Press.
Polymerase Chain Reaction (PCR). What’s the point of PCR? PCR, or the polymerase chain reaction, makes copies of a specific piece of DNA PCR allows you.
DIAGNOSIS OF WILSON’S DISEASE – A 20-YEAR AUDIT Geetha Rathnayake 1, Mirette Saad 2, Kay Weng Choy 1, James CG Doery 1,3 1 Monash Pathology, Monash Medical.
Fran D. Kendall, M.D. Virtual Medical Practice, LLC Biochemical Genetics, Pediatrics Metabolic, Mitochondrial & Inherited Disorders Mitochondrial Disease.
Laboratory Quality Control
Ch.12 Immunology Applications
Unexplained gastrointestinal symptoms: Think mitochondrial disease
GENETICS TESTING.
Preimplantation Genetic Diagnosis (PGD)
Rapid Molecular Analysis of the STAT3 Gene in Job Syndrome of Hyper-IgE and Recurrent Infectious Diseases  Attila Kumánovics, Carl T. Wittwer, Robert.
Genetic Testing Result Means. Before Genetic Testing  The result of genetic testing can be life changing.  It is important for patients and their families.
Clinical Biochemistry An Introduction
Investigation strategies and methods
Medical Laboratory Science
Oral mucosa as a source of Mycobacterium leprae infection and transmission, and implications of bacterial DNA detection and the immunological status 
Detection of fungal DNA in lysis–centrifugation blood culture for the diagnosis of invasive candidiasis in neonatal patients  L. Trovato, P. Betta, M.G.
West Midlands Regional Genetics Laboratory
PCP: Diagnosis Dr. Rita O. Oladele Consultant Clinical Microbiologist
Introduction To Medical Technology
Nat. Rev. Neurol. doi: /nrneurol
PCP: Diagnosis Dr. Rita O. Oladele Consultant Clinical Microbiologist
Inheritance of Mitochondrial DNA Recombinants in Double-Heteroplasmic Families: Potential Implications for Phylogenetic Analysis  Gábor Zsurka, Kevin.
Detection of Common Disease-Causing Mutations in Mitochondrial DNA (Mitochondrial Encephalomyopathy, Lactic Acidosis with Stroke-Like Episodes MTTL
Rapid and Sensitive Real-Time Polymerase Chain Reaction Method for Detection and Quantification of 3243A>G Mitochondrial Point Mutation  Rinki Singh,
Subcommittee on Genetic Modification Representative Nathaniel Smith
Speakers: Lissa Poincenot & Dr. Nancy Newman June 28, 2019
Presentation transcript:

Diagnostic mtDNA analysis in body fluids other than blood Sarah Ball 1, George Gray 1, Ros Quinlivan 3, Paul Brown 4, Chris Hendriksz 2 Birmingham Children’s Hospital, Departments of Clinical Chemistry 1, Clinical IMD 2 and Neurology 3 and West Midlands Regional Molecular Genetics Service, Birmingham Women's’ Hospital 4

mtDNA disorders Unusual genetic features: Maternal inheritance Maternal inheritance Heteroplasmy Heteroplasmy Variable levels of mutation load in different tissues Variable levels of mutation load in different tissues

Samples for DNA testing Mutation level in DNA extracted from blood may be below the level of detectability Mutation level in DNA extracted from blood may be below the level of detectability If strong suspicion of mtDNA disease testing lab will request DNA from a biopsy of the affected tissue (e.g. liver, kidney, muscle) If strong suspicion of mtDNA disease testing lab will request DNA from a biopsy of the affected tissue (e.g. liver, kidney, muscle) Tissue biopsy is expensive and invasive Tissue biopsy is expensive and invasive Difficulty reaching diagnosis when appropriate samples are not available Difficulty reaching diagnosis when appropriate samples are not available

Non-invasive samples West Midlands Inherited Metabolic Diseases Laboratory investigating use of non-invasive samples for testing for mtDNA disorders West Midlands Inherited Metabolic Diseases Laboratory investigating use of non-invasive samples for testing for mtDNA disorders Urinary epithelium cells from 30ml early morning urine sample Urinary epithelium cells from 30ml early morning urine sample Buccal mucosal cells from saliva or buccal swab Buccal mucosal cells from saliva or buccal swab

DNA extracted from urine MW marker Urine DNA 1 Urine DNA 2 Urine DNA 3 20kb +

Amplification of DNA extracted from urine: m.3243A>G (MELAS) amplicon MW marker Urine 1 Urine 2 Urine 3 Urine 4 QC sample No DNA control 300bp PCR product

Amplification of DNA extracted from buccal swab: m.3243A>G (MELAS) amplicon MW marker Buccal scrape DNA 1 Buccal scrape DNA2 QC sample No DNA control 300 bp PCR product

Amplification of DNA extracted from urine: m.8344A>G (MERRF) amplicon MW marker Urine DNA 1 Urine DNA 2 Urine DNA 3 Urine DNA 4 QC sample No DNA control 100bp PCR product

Clinical samples to test Ready to test MELAS or MERRF mutations in saliva and urine Ready to test MELAS or MERRF mutations in saliva and urine Awaiting samples Awaiting samples

Analysis of m.8344A>G Index case: MK Index case: MK 8 year old boy with muscle weakness 8 year old boy with muscle weakness Blood DNA m.8344A>G mutation at a high level of heteroplasmy Blood DNA m.8344A>G mutation at a high level of heteroplasmy Result consistent with a diagnosis of myoclonic epilepsy with ragged red fibres (MERRF) Result consistent with a diagnosis of myoclonic epilepsy with ragged red fibres (MERRF)

Further studies on m.8344A>G MK’s mother, TK, has myoclonic epilepsy MK’s mother, TK, has myoclonic epilepsy TK is needle phobic and had not had genetic testing TK is needle phobic and had not had genetic testing Following appropriate genetic counselling obtained urine and saliva samples from MK and TK Following appropriate genetic counselling obtained urine and saliva samples from MK and TK

100bp MK venous blood 2 MK urine 3 MK saliva 4 TK urine 5 TK saliva 6 mutation absent QC sample 7 mutation present QC sample 8 no template control 100bp 73bp Analysis of m.8344A>G in MK and TK

Results Able to diagnose m.8344A>G mutation in urine and saliva samples Able to diagnose m.8344A>G mutation in urine and saliva samples Confirmed the diagnosis in the index case Confirmed the diagnosis in the index case Made a new diagnosis in his mother Made a new diagnosis in his mother In the index case mutation shows a level of heteroplasmy in saliva and urine equal to or greater than the level in blood In the index case mutation shows a level of heteroplasmy in saliva and urine equal to or greater than the level in blood

Further case 1 Index case: JT Index case: JT 38 year old female with muscle weakness 38 year old female with muscle weakness Blood DNA showed m.3243A>G mutation at very low level of heteroplasmy (~10%) Blood DNA showed m.3243A>G mutation at very low level of heteroplasmy (~10%) Urine and saliva samples showed higher levels of heteroplasmy Urine and saliva samples showed higher levels of heteroplasmy

Further case 2 Index case: AV Index case: AV 8 year old boy with Leigh Syndrome 8 year old boy with Leigh Syndrome Blood DNA showed m.9176T>C mutation at high level of heteroplasmy Blood DNA showed m.9176T>C mutation at high level of heteroplasmy Urine sample showed mutation at a very high level approaching homoplasmy Urine sample showed mutation at a very high level approaching homoplasmy

Further work Further studies on patients with known mutations are required to formally validate this approach Further studies on patients with known mutations are required to formally validate this approach Need to compare urine and saliva mutation results with tissue biopsy specimens from the same patients to properly evaluate the use of these specimens for testing for mtDNA mutations Need to compare urine and saliva mutation results with tissue biopsy specimens from the same patients to properly evaluate the use of these specimens for testing for mtDNA mutations We believe this is a useful addition to the test repertoire of the laboratory testing for mtDNA mutations which may avoid unnecessary tissue biopsies for some patients We believe this is a useful addition to the test repertoire of the laboratory testing for mtDNA mutations which may avoid unnecessary tissue biopsies for some patients